Total amount: € 0,00
Indexed/Abstracted in: CAB, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,532
Online ISSN 1827-1715
Cakmak A., Baba F., Cakmak S., Shermatov K., Karazeybek H.
1 Department of Pediatrics, Harran University School of Medicine, Sanliurfa, Turkey
2 Department of Pathology, Harran University School of Medicine, Sanliurfa, Turkey
3 Department of Ophtalmology, Dicle University School of Medicine, Sanliurfa, Turkey
4 Department of Pediatrics, Harran University School of Medicine, Sanliurfa, Turkey
The authors assessed the clinical efficacy, tolerability and safety of acitretin in a patient with ichthyosis. A newborn infant with ichthyosis who presented at birth with collodion baby appearance, was treated with acitretin. A moderate response to acitretin therapy (1 mg/kg/day) administered for 6 months was observed, with improvement in cutaneous lesions. Clinical improvement was achieved shortly after treatment. The treatment resulted in a satisfactory improvement in the skin condition of the case. The tolerance to the drug was good. Side effects were not observed. The oral acitretin treatment is efficient in severe congenital ichthyosis.